XOMA Appoints Fred Kurland as Chief Financial Officer
January 05, 2009 08:00 ET
|
XOMA Corporation
BERKELEY, Calif., Jan. 5, 2009 (GLOBE NEWSWIRE) -- XOMA, Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today the appointment of Fred Kurland to the...
XOMA Appoints John Varian to Board of Directors
December 11, 2008 08:00 ET
|
XOMA Corporation
BERKELEY, Calif., Dec. 11, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today the addition of John Varian to its...
XOMA Provides Clinical Plan Update On Diabetes Drug Candidate
December 10, 2008 08:00 ET
|
XOMA Corporation
BERKELEY, Calif., Dec. 10, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) announced that it has accelerated its plans to initiate a Phase 2 clinical trial of its antibody drug candidate, XOMA 052,...
XOMA Speaks On Inflammation and Rheumatology Panel At RBC Capital Markets Healthcare Conference
December 04, 2008 08:00 ET
|
XOMA Corporation
BERKELEY, Calif., Dec. 4, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steve Engle, Chairman and CEO of...
XOMA Reports Third Quarter 2008 Financial Results
November 10, 2008 16:01 ET
|
XOMA Corporation
BERKELEY, Calif., Nov. 10, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced its results for the quarter ended...
XOMA Restructures Drug Development Collaboration Including Oncology Drug Candidate HCD122
November 10, 2008 08:01 ET
|
XOMA Corporation
BERKELEY, Calif., Nov. 10, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced the restructuring of its product...
XOMA Appoints Steve Doberstein to Vice President of Research
October 28, 2008 08:05 ET
|
XOMA Corporation
BERKELEY, Calif., Oct. 28, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced the appointment of Stephen K....
XOMA Presents Data On XOMA 052, An Anti-IL-1 Beta Antibody, in Rheumatoid Arthritis and Acute Gout Animal Models
October 25, 2008 20:00 ET
|
XOMA Corporation
BERKELEY, Calif., Oct. 25, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, today announced that its poster titled "Efficacy Of...
XOMA to Present At the BIO Investor Forum On October 30
October 23, 2008 16:35 ET
|
XOMA Corporation
BERKELEY, Calif., Oct. 23, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, XOMA's Chairman and...
XOMA Enters Into $60 Million Committed Equity Financing Facility
October 22, 2008 08:05 ET
|
XOMA Corporation
BERKELEY, Calif., Oct. 22, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) today announced that it has entered into a committed equity financing facility under which it has the option to sell up to...